Prelude Capital Management’s Alkermes ALKS Stock Holding History

Prelude Capital Management’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,928	Closed	-$599K	–	1228
2026 Q1	$599K	Buy	+16,928	New	+$525K	0.05%	441
2021 Q3	–	Sell	-10,914	Closed	-$268K	–	1699
2021 Q2	$268K	Buy	+10,914	New	+$243K	0.01%	1247
2020 Q1	–	Sell	-8,809	Closed	-$180K	–	1398
2019 Q4	$180K	Buy	+8,809	New	+$175K	0.01%	885
2016 Q4	–	Sell	-258	Closed	-$13.8K	–	1521
2016 Q3	$12K	Sell	258 -1,897	-88%	-$90.2K	﹤0.01%	1405
2016 Q2	$93K	Sell	2,155 -4,212	-66%	-$174K	0.01%	793
2016 Q1	$218K	Sell	6,367 -1,851	-23%	-$73.1K	0.03%	526
2015 Q4	$652K	Buy	8,218 +2,045	+33%	+$143K	0.1%	222
2015 Q3	$362K	Sell	6,173 -427	-6%	-$28.2K	0.05%	366
2015 Q2	$425K	Hold	6,600	–	–	0.06%	346
2015 Q1	$402K	Buy	6,600 +142	+2%	+$9.7K	0.06%	400
2014 Q4	$378K	Buy	+6,458	New	+$329K	0.06%	398
2013 Q4	–	Sell	-7,200	Closed	-$242K	–	1594
2013 Q3	$242K	Buy	+7,200	New	+$234K	0.04%	479

Other funds holding ALKS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Prelude Capital Management's ALKS Position: Q2 2026 in Review

Prelude Capital Management sold out of Alkermes (ALKS) in Q2 2026, closing a stake of 16,928 shares — an estimated $599K sold.

Prelude Capital Management first reported a position in ALKS in Q3 2013 and held it in 12 quarters. The position peaked at $652K in Q4 2015. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

Prelude Capital Management reported no remaining Alkermes position as of Q2 2026 after selling out during the quarter.
Prelude Capital Management sold 16,928 Alkermes shares in Q2 2026, an estimated $599K.
Prelude Capital Management first reported a position in Alkermes in Q3 2013 and held it in 12 quarters.
Prelude Capital Management's Alkermes position peaked at $652K in Q4 2015.
424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.